Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Er:YAG laser plus halometasone + triclosan cream vs laser plus compound betamethasone injection for keloids
ChiCTR2600119062Phase 2Not yet recruiting
- Sponsor
- First Affiliated Hospital of Xiamen University
- Start
- Feb 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of halometasone, Triclosan and betamethasone in keloid (2 arms), sponsored by First Affiliated Hospital of Xiamen University. Primary endpoint: Pigmentation (Vancouver Scar Scale pigmentation component). Planned start Feb 2026; status: not yet recruiting.
02
Drugs
halometasoneTriclosanbetamethasone
03
Conditions
keloid
Beyond the preview
Go deeper on ChiCTR2600119062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600119062.